Innate Pharma S.A. ROE Ratio 2011-2026 | IPHA

Annual ROE Ratio Innate Pharma S.A.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-41.02	-9.55	1.82	-56.29	-	-	-	-	-	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
1.82	-56.29	-26.26

ROE Ratio of other stocks in the Biotechnology industry

Issuer	ROE Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	15.76	-	2.43 %	$ 254 M	Germany
BioNTech SE BNTX	1.11	$ 97.54	2.14 %	$ 27.2 B	Germany
Aligos Therapeutics ALGS	-45.18	$ 8.65	8.19 %	$ 85.5 M	USA
Alterity Therapeutics Limited ATHE	-36.22	$ 3.63	-2.42 %	$ 8.73 B	Australia
I-Mab IMAB	-85.31	-	-	$ 866 M	China
AlloVir ALVR	-55.11	-	4.14 %	$ 49.1 M	USA
Applied Molecular Transport AMTI	-207.64	-	-	$ 10.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	5.18	-	-	$ 40.3 B	USA
Genfit SA GNFT	626.29	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	-751.94	-	-13.47 %	$ 169 M	France
Applied Therapeutics APLT	698.49	-	-	$ 8.42 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	-115.61	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	-330.29	-	-18.52 %	$ 27.3 M	Britain
Esperion Therapeutics ESPR	7.51	$ 2.14	-1.38 %	$ 445 M	USA
Evogene Ltd. EVGN	-41.09	$ 0.81	-0.07 %	$ 27.9 M	Israel
Amphastar Pharmaceuticals AMPH	12.44	$ 20.47	0.49 %	$ 957 M	USA
Genmab A/S GMAB	24.88	$ 28.2	-0.18 %	$ 18 B	Danmark
Grifols, S.A. GRFS	9.2	$ 8.19	-0.24 %	$ 6.83 B	Spain
GT Biopharma GTBP	-489.96	$ 0.36	-2.82 %	$ 1.98 M	USA
Acorda Therapeutics ACOR	160.08	-	-24.86 %	$ 820 K	USA
Институт стволовых клеток человека ISKJ	17.55	-	-	-	Russia
Halozyme Therapeutics HALO	649.18	$ 67.06	-1.12 %	$ 8.04 B	USA
Adverum Biotechnologies ADVM	-185.15	-	-	$ 86.2 M	USA
Advaxis ADXS	196.88	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	-401.79	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	51843.24	-	-10.17 %	$ 12.2 K	USA
Harmony Biosciences Holdings HRMY	18.24	$ 28.69	-0.69 %	$ 1.65 B	USA
Aeglea BioTherapeutics AGLE	-21.7	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	-16.39	$ 1.41	0.71 %	$ 363 M	USA
Applied Genetic Technologies Corporation AGTC	-62.37	-	-	$ 26.5 M	USA
Allakos ALLK	-110.0	-	-	$ 28.6 M	USA
Can-Fite BioPharma Ltd. CANF	-175.75	$ 2.96	1.37 %	$ 4.87 M	Israel
Aptinyx APTX	-169.38	-	-39.0 %	$ 4.57 M	USA
Aquestive Therapeutics AQST	248.9	$ 4.16	1.84 %	$ 445 M	USA
Aravive ARAV	-716.17	-	-13.39 %	$ 1.45 M	USA
Arcutis Biotherapeutics ARQT	-8.52	$ 24.01	-0.85 %	$ 3.05 B	USA
ImmuCell Corporation ICCC	-3.84	$ 7.12	1.14 %	$ 64.3 M	USA
AIkido Pharma AIKI	-32.34	-	1.93 %	$ 17.4 M	USA
Celldex Therapeutics CLDX	-49.08	$ 32.24	-	$ 2.14 B	USA
Autolus Therapeutics plc AUTL	-161.42	$ 1.48	-0.67 %	$ 394 M	Britain
Aptose Biosciences APTO	93.75	-	-45.71 %	$ 1.2 M	Canada
Immatics N.V. IMTX	1.79	$ 10.48	0.43 %	$ 659 M	Germany
Cidara Therapeutics CDTX	-103.99	-	-	$ 1.41 B	USA
Incyte Corporation INCY	24.9	$ 94.86	-1.26 %	$ 18.5 B	USA
AVROBIO AVRO	12.83	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	3458.87	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	-71.51	$ 2.61	2.35 %	$ 16.4 M	USA
InflaRx N.V. IFRX	-43.64	$ 1.05	4.5 %	$ 152 M	Germany
AstraZeneca PLC AZN	20.44	-	-	$ 96.9 B	Britain
Inventiva S.A. IVA	-30.23	$ 5.18	-1.52 %	$ 138 M	France